396 related articles for article (PubMed ID: 28276260)
21. Infections of
Kitisin T; Muangkaew W; Sukphopetch P
Front Cell Infect Microbiol; 2022; 12():1039336. PubMed ID: 36389163
[TBL] [Abstract][Full Text] [Related]
22. Chlorogenic acid delays the progression of Parkinson's disease via autophagy induction in
He CL; Tang Y; Wu JM; Long T; Yu L; Teng JF; Qiu WQ; Pan R; Yu CL; Qin DL; Wu AG; Zhou XG
Nutr Neurosci; 2023 Jan; 26(1):11-24. PubMed ID: 34927571
[TBL] [Abstract][Full Text] [Related]
23. Beneficial Effects of Cyclic Ether 2-Butoxytetrahydrofuran from Sea Cucumber
Tangrodchanapong T; Sornkaew N; Yurasakpong L; Niamnont N; Nantasenamat C; Sobhon P; Meemon K
Molecules; 2021 Apr; 26(8):. PubMed ID: 33920352
[TBL] [Abstract][Full Text] [Related]
24. Peiminine Reduces ARTS-Mediated Degradation of XIAP by Modulating the PINK1/Parkin Pathway to Ameliorate 6-Hydroxydopamine Toxicity and α-Synuclein Accumulation in Parkinson's Disease Models In Vivo and In Vitro.
Hsu YL; Hung HS; Tsai CW; Liu SP; Chiang YT; Kuo YH; Shyu WC; Lin SZ; Fu RH
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638579
[TBL] [Abstract][Full Text] [Related]
25. Alpha-linolenic acid suppresses dopaminergic neurodegeneration induced by 6-OHDA in C. elegans.
Shashikumar S; Pradeep H; Chinnu S; Rajini PS; Rajanikant GK
Physiol Behav; 2015 Nov; 151():563-9. PubMed ID: 26300470
[TBL] [Abstract][Full Text] [Related]
26. 2-Butoxytetrahydrofuran and Palmitic Acid from
Jattujan P; Srisirirung S; Watcharaporn W; Chumphoochai K; Kraokaew P; Sanguanphun T; Prasertsuksri P; Thongdechsri S; Sobhon P; Meemon K
Pharmaceuticals (Basel); 2022 Nov; 15(11):. PubMed ID: 36355546
[TBL] [Abstract][Full Text] [Related]
27. Anti-α-synuclein Toxicity and Anti-neurodegenerative Role of Chrysin in Transgenic
Muhammad F; Liu Y; Wang N; Zhao L; Zhou Y; Yang H; Li H
ACS Chem Neurosci; 2022 Feb; 13(4):442-453. PubMed ID: 35118868
[TBL] [Abstract][Full Text] [Related]
28. Small molecule inhibits α-synuclein aggregation, disrupts amyloid fibrils, and prevents degeneration of dopaminergic neurons.
Pujols J; Peña-Díaz S; Lázaro DF; Peccati F; Pinheiro F; González D; Carija A; Navarro S; Conde-Giménez M; García J; Guardiola S; Giralt E; Salvatella X; Sancho J; Sodupe M; Outeiro TF; Dalfó E; Ventura S
Proc Natl Acad Sci U S A; 2018 Oct; 115(41):10481-10486. PubMed ID: 30249646
[TBL] [Abstract][Full Text] [Related]
29. Neuroprotective effect of damaurone D in a C. elegans model of Parkinson's disease.
Lee SH; Han YT; Cha DS
Neurosci Lett; 2021 Mar; 747():135623. PubMed ID: 33482307
[TBL] [Abstract][Full Text] [Related]
30. Levodopa-Reduced
Johnson SL; Park HY; DaSilva NA; Vattem DA; Ma H; Seeram NP
Nutrients; 2018 Aug; 10(9):. PubMed ID: 30131460
[No Abstract] [Full Text] [Related]
31. Scorpion venom heat-resistant synthetic peptide protects dopamine neurons against 6-hydroxydopamine neurotoxicity in C. elegans.
Guo SY; Guan RX; Chi XD; Yue-Zhang ; Sui AR; Zhao W; Supratik K; Yang JY; Zhao J; Li S
Brain Res Bull; 2022 Nov; 190():195-203. PubMed ID: 36191729
[TBL] [Abstract][Full Text] [Related]
32. Rose essential oil diminishes dopaminergic neuron degenerations and reduces α-synuclein aggregation in Caenorhabditis elegans models of Parkinson's disease.
Muhammad F; Liu Y; Wang N; Zhao L; Zhou Y; Yang H; Li H
Phytother Res; 2023 Jul; 37(7):2877-2893. PubMed ID: 36920348
[TBL] [Abstract][Full Text] [Related]
33. Protective effect of plastrum testudinis extract on dopaminergic neurons in a Parkinson's disease model through DNMT1 nuclear translocation and SNCA's methylation.
Ye S; Zhong J; Huang J; Chen L; Yi L; Li X; Lv J; Miao J; Li H; Chen D; Li C
Biomed Pharmacother; 2021 Sep; 141():111832. PubMed ID: 34153844
[TBL] [Abstract][Full Text] [Related]
34. Valproic acid ameliorates C. elegans dopaminergic neurodegeneration with implications for ERK-MAPK signaling.
Kautu BB; Carrasquilla A; Hicks ML; Caldwell KA; Caldwell GA
Neurosci Lett; 2013 Apr; 541():116-9. PubMed ID: 23485787
[TBL] [Abstract][Full Text] [Related]
35. Torsin-mediated protection from cellular stress in the dopaminergic neurons of Caenorhabditis elegans.
Cao S; Gelwix CC; Caldwell KA; Caldwell GA
J Neurosci; 2005 Apr; 25(15):3801-12. PubMed ID: 15829632
[TBL] [Abstract][Full Text] [Related]
36. Application of a C. elegans dopamine neuron degeneration assay for the validation of potential Parkinson's disease genes.
Berkowitz LA; Hamamichi S; Knight AL; Harrington AJ; Caldwell GA; Caldwell KA
J Vis Exp; 2008 Jul; (17):. PubMed ID: 19066512
[TBL] [Abstract][Full Text] [Related]
37. Studying Parkinson's disease using Caenorhabditis elegans models in microfluidic devices.
Youssef K; Tandon A; Rezai P
Integr Biol (Camb); 2019 May; 11(5):186-207. PubMed ID: 31251339
[TBL] [Abstract][Full Text] [Related]
38. Modeling dopamine neuron degeneration in Caenorhabditis elegans.
Tucci ML; Harrington AJ; Caldwell GA; Caldwell KA
Methods Mol Biol; 2011; 793():129-48. PubMed ID: 21913098
[TBL] [Abstract][Full Text] [Related]
39. Gastrodin protects dopaminergic neurons via insulin-like pathway in a Parkinson's disease model.
Yan J; Yang Z; Zhao N; Li Z; Cao X
BMC Neurosci; 2019 Jun; 20(1):31. PubMed ID: 31208386
[TBL] [Abstract][Full Text] [Related]
40. Saponin-enriched extracts from body wall and Cuvierian tubule of Holothuria leucospilota reduce fat accumulation and suppress lipogenesis in Caenorhabditis elegans.
Chumphoochai K; Chalorak P; Suphamungmee W; Sobhon P; Meemon K
J Sci Food Agric; 2019 Jun; 99(8):4158-4166. PubMed ID: 30767223
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
